Report cover image

Global Anti-tumor Drug Competitive Landscape Professional Research Report 2025

Publisher DIResearch
Published Jan 23, 2025
Length 170 Pages
SKU # DIR19532176

Description

Global Anti-tumor Drug Competitive Landscape Professional Research Report 2025



Research Summary

An anti-tumor drug is a type of medication used to treat cancer by either stopping or slowing down the growth of cancer cells. They work by targeting specific molecules or processes that are essential for the growth and survival of cancer cells. Anti-tumor drugs can be administered through injections, tablets, capsules, or intravenous infusions. They can be used alone or in combination with other treatments like radiation therapy or surgery. Examples of anti-tumor drugs include chemotherapy agents, immunotherapy agents, targeted therapy agents, and hormone therapies. The choice of the drug will depend on the type of cancer and the stage of the disease.

According to DIResearch's in-depth investigation and research, the global Anti-tumor Drug market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.

The major global  manufacturers of Anti-tumor Drug include Roche, Novartis, Celgene, Bristol-Myers Squibb, Amgen, Johnson & Johnson, Pfizer, Takeda, Eli Lilly, AstraZeneca, Astellas, Merck & Co, Sanofi, Bayer, Biogen Idec, Eisai, Teva, Otsuka etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Anti-tumor Drug. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Anti-tumor Drug market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Anti-tumor Drug market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Anti-tumor Drug industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.  

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Anti-tumor Drug Include:

Roche

Novartis

Celgene

Bristol-Myers Squibb

Amgen

Johnson & Johnson

Pfizer

Takeda

Eli Lilly

AstraZeneca

Astellas

Merck & Co

Sanofi

Bayer

Biogen Idec

Eisai

Teva

Otsuka

Anti-tumor Drug Product Segment Include:

Cytotoxic Drugs

Non-cytotoxic Drugs

Anti-tumor Drug Product Application Include:

Alkylating Agents

Anti-Metabolism Drugs

Platinum Antineoplastic Agents

Anthracycline Antitumor Drugs

Microtubule Stabilizer

Endocrine Therapy Drugs

Immunotherapy Drugs

Gene Therapy Drugs

Targeted Antineoplastic Drugs

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Anti-tumor Drug Industry PESTEL Analysis

Chapter 3: Global Anti-tumor Drug Industry Porter’s Five Forces Analysis

Chapter 4: Global Anti-tumor Drug Major Regional Market Size and Forecast Analysis

Chapter 5: Global Anti-tumor Drug Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Passenger Anti-tumor Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Anti-tumor Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Anti-tumor Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Anti-tumor Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Anti-tumor Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Anti-tumor Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Anti-tumor Drug Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

170 Pages
1 Anti-tumor Drug Market Overview
1.1 Product Definition and Statistical Scope
1.2 Anti-tumor Drug Product by Type
1.2.1 Cytotoxic Drugs
1.2.2 Non-cytotoxic Drugs
1.3 Anti-tumor Drug Product by Application
1.3.1 Alkylating Agents
1.3.2 Anti-Metabolism Drugs
1.3.3 Platinum Antineoplastic Agents
1.3.4 Anthracycline Antitumor Drugs
1.3.5 Microtubule Stabilizer
1.3.6 Endocrine Therapy Drugs
1.3.7 Immunotherapy Drugs
1.3.8 Gene Therapy Drugs
1.3.9 Targeted Antineoplastic Drugs
1.4 Global Anti-tumor Drug Market Size Analysis (2020-2032)
1.5 Anti-tumor Drug Market Development Status and Trends
1.5.1 Anti-tumor Drug Industry Development Status Analysis
1.5.2 Anti-tumor Drug Industry Development Trends Analysis
2 Anti-tumor Drug Market PESTEL Analysis
2.1 Political Factors Analysis
2.2 Economic Factors Analysis
2.3 Social Factors Analysis
2.4 Technological Factors Analysis
2.5 Environmental Factors Analysis
2.6 Legal Factors Analysis
3 Anti-tumor Drug Market Porter's Five Forces Analysis
3.1 Competitive Rivalry
3.2 Threat of New Entrants
3.3 Bargaining Power of Suppliers
3.4 Bargaining Power of Buyers
3.5 Threat of Substitutes
4 Global Anti-tumor Drug Market Analysis by Regions
4.1 Anti-tumor Drug Overall Market: 2024 VS 2025 VS 2032
4.2 Global Anti-tumor Drug Revenue and Forecast Analysis (2020-2032)
4.2.1 Global Anti-tumor Drug Revenue and Market Share by Region (2020-2025)
4.2.2 Global Anti-tumor Drug Revenue Forecast by Region (2026-2032)
5 Global Anti-tumor Drug Market Size by Type and Application
5.1 Global Anti-tumor Drug Market Size by Type (2020-2032)
5.2 Global Anti-tumor Drug Market Size by Application (2020-2032)
6 North America
6.1 North America Anti-tumor Drug Market Size and Growth Rate Analysis (2020-2032)
6.2 North America Key Manufacturers Analysis
6.3 North America Anti-tumor Drug Market Size by Type
6.4 North America Anti-tumor Drug Market Size by Application
6.5 North America Anti-tumor Drug Market Size by Country
6.5.1 US
6.5.2 Canada
7 Europe
7.1 Europe Anti-tumor Drug Market Size and Growth Rate Analysis (2020-2032)
7.2 Europe Key Manufacturers Analysis
7.3 Europe Anti-tumor Drug Market Size by Type
7.4 Europe Anti-tumor Drug Market Size by Application
7.5 Europe Anti-tumor Drug Market Size by Country
7.5.1 Germany
7.5.2 France
7.5.3 United Kingdom
7.5.4 Italy
7.5.5 Spain
7.5.6 Benelux
8 China
8.1 China Anti-tumor Drug Market Size and Growth Rate Analysis (2020-2032)
8.2 China Key Manufacturers Analysis
8.3 China Anti-tumor Drug Market Size by Type
8.4 China Anti-tumor Drug Market Size by Application
9 APAC (excl. China)
9.1 APAC (excl. China) Anti-tumor Drug Market Size and Growth Rate Analysis (2020-2032)
9.2 APAC (excl. China) Key Manufacturers Analysis
9.3 APAC (excl. China) Anti-tumor Drug Market Size by Type
9.4 APAC (excl. China) Anti-tumor Drug Market Size by Application
9.5 APAC (excl. China) Anti-tumor Drug Market Size by Country
9.5.1 Japan
9.5.2 South Korea
9.5.3 India
9.5.4 Australia
9.5.5 Southeast Asia
10 Latin America
10.1 Latin America Anti-tumor Drug Market Size and Growth Rate Analysis (2020-2032)
10.2 Latin America Key Manufacturers Analysis
10.3 Latin America Anti-tumor Drug Market Size by Type
10.4 Latin America Anti-tumor Drug Market Size by Application
10.5 Latin America Anti-tumor Drug Market Size by Country
10.5.1 Mexico
10.5.2 Brazil
11 Middle East & Africa
11.1 Middle East & Africa Anti-tumor Drug Market Size and Growth Rate Analysis (2020-2032)
11.2 Middle East & Africa Key Manufacturers Analysis
11.3 Middle East & Africa Anti-tumor Drug Market Size by Type
11.4 Middle East & Africa Anti-tumor Drug Market Size by Application
11.5 Middle East & Africa Anti-tumor Drug Market Size by Country
11.5.1 Saudi Arabia
11.5.2 South Africa
12 Competition by Manufacturers
12.1 Global Anti-tumor Drug Market Revenue by Key Manufacturers (2021-2025)
12.2 Anti-tumor Drug Competitive Landscape Analysis and Market Dynamic
12.2.1 Anti-tumor Drug Competitive Landscape Analysis
12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
12.2.3 Market Dynamic
13 Key Companies Analysis
13.1 Roche
13.1.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.1.2 Roche Anti-tumor Drug Product Portfolio
13.1.3 Roche Anti-tumor Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.2 Novartis
13.2.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.2.2 Novartis Anti-tumor Drug Product Portfolio
13.2.3 Novartis Anti-tumor Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.3 Celgene
13.3.1 Celgene Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.3.2 Celgene Anti-tumor Drug Product Portfolio
13.3.3 Celgene Anti-tumor Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.4 Bristol-Myers Squibb
13.4.1 Bristol-Myers Squibb Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.4.2 Bristol-Myers Squibb Anti-tumor Drug Product Portfolio
13.4.3 Bristol-Myers Squibb Anti-tumor Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.5 Amgen
13.5.1 Amgen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.5.2 Amgen Anti-tumor Drug Product Portfolio
13.5.3 Amgen Anti-tumor Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.6 Johnson & Johnson
13.6.1 Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.6.2 Johnson & Johnson Anti-tumor Drug Product Portfolio
13.6.3 Johnson & Johnson Anti-tumor Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.7 Pfizer
13.7.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.7.2 Pfizer Anti-tumor Drug Product Portfolio
13.7.3 Pfizer Anti-tumor Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.8 Takeda
13.8.1 Takeda Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.8.2 Takeda Anti-tumor Drug Product Portfolio
13.8.3 Takeda Anti-tumor Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.9 Eli Lilly
13.9.1 Eli Lilly Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.9.2 Eli Lilly Anti-tumor Drug Product Portfolio
13.9.3 Eli Lilly Anti-tumor Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.10 AstraZeneca
13.10.1 AstraZeneca Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.10.2 AstraZeneca Anti-tumor Drug Product Portfolio
13.10.3 AstraZeneca Anti-tumor Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.11 Astellas
13.11.1 Astellas Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.11.2 Astellas Anti-tumor Drug Product Portfolio
13.11.3 Astellas Anti-tumor Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.12 Merck & Co
13.12.1 Merck & Co Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.12.2 Merck & Co Anti-tumor Drug Product Portfolio
13.12.3 Merck & Co Anti-tumor Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.13 Sanofi
13.13.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.13.2 Sanofi Anti-tumor Drug Product Portfolio
13.13.3 Sanofi Anti-tumor Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.14 Bayer
13.14.1 Bayer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.14.2 Bayer Anti-tumor Drug Product Portfolio
13.14.3 Bayer Anti-tumor Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.15 Biogen Idec
13.15.1 Biogen Idec Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.15.2 Biogen Idec Anti-tumor Drug Product Portfolio
13.15.3 Biogen Idec Anti-tumor Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.16 Eisai
13.16.1 Eisai Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.16.2 Eisai Anti-tumor Drug Product Portfolio
13.16.3 Eisai Anti-tumor Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.17 Teva
13.17.1 Teva Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.17.2 Teva Anti-tumor Drug Product Portfolio
13.17.3 Teva Anti-tumor Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.18 Otsuka
13.18.1 Otsuka Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.18.2 Otsuka Anti-tumor Drug Product Portfolio
13.18.3 Otsuka Anti-tumor Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
14 Industry Chain Analysis
14.1 Anti-tumor Drug Industry Chain Analysis
14.2 Anti-tumor Drug Industry Raw Material and Suppliers Analysis
14.2.1 Anti-tumor Drug Key Raw Material Supply Analysis
14.2.2 Raw Material Suppliers and Contact Information
14.3 Anti-tumor Drug Typical Downstream Customers
14.4 Anti-tumor Drug Sales Channel Analysis
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology/Research Approach
16.2 Research Scope
16.3 Benchmarks and Assumptions
16.4 Date Source
16.4.1 Primary Sources
16.4.2 Secondary Sources
16.5 Data Cross Validation
16.6 Disclaimer

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us